Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).

NCT06581848 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Elranatamab

Sponsor

Pfizer